89Bio Inc - ESG Rating & Company Profile powered by AI
This report of 89Bio Inc incorporates information from across the internet and also from public disclosures by 89Bio Inc. Check the end of the page for potential risks for 89Bio Inc based on sector, location and marketcap. This SDG assessment for 89Bio Inc indicates the company's transparency towards the United Nations SDGs.
89Bio Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.0, social score of 3.2 and governance score of 4.8.
3.3
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1234 | Quanterix Corp | 3.4 | Medium |
1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
1253 | 89Bio Inc | 3.3 | Medium |
1253 | Calithera Biosciences Inc | 3.3 | Medium |
1253 | Cara Therapeutics Inc | 3.3 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does 89Bio Inc have an accelerator or VC vehicle to help deliver innovation?
Does 89Bio Inc disclose current and historical energy intensity?
Does 89Bio Inc report the average age of the workforce?
Does 89Bio Inc reference operational or capital allocation in relation to climate change?
Does 89Bio Inc disclose its ethnicity pay gap?
Does 89Bio Inc disclose cybersecurity risks?
Does 89Bio Inc offer flexible work?
Does 89Bio Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does 89Bio Inc disclose the number of employees in R&D functions?
Does 89Bio Inc conduct supply chain audits?
Does 89Bio Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does 89Bio Inc conduct 360 degree staff reviews?
Does 89Bio Inc disclose the individual responsible for D&I?
Does 89Bio Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does 89Bio Inc disclose current and / or historical scope 2 emissions?
Does 89Bio Inc disclose water use targets?
Does 89Bio Inc have careers partnerships with academic institutions?
Did 89Bio Inc have a product recall in the last two years?
Does 89Bio Inc disclose incidents of discrimination?
Does 89Bio Inc allow for Work Councils/Collective Agreements to be formed?
Has 89Bio Inc issued a profit warning in the past 24 months?
Does 89Bio Inc disclose parental leave metrics?
Does 89Bio Inc disclose climate scenario or pathway analysis?
Does 89Bio Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does 89Bio Inc disclose the pay ratio of women to men?
Does 89Bio Inc support suppliers with sustainability related research and development?
Does 89Bio Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does 89Bio Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is 89Bio Inc involved in embryonic stem cell research?
Does 89Bio Inc disclose GHG and Air Emissions intensity?
Does 89Bio Inc disclose its waste policy?
Does 89Bio Inc report according to TCFD requirements?
Does 89Bio Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does 89Bio Inc disclose energy use targets?
Does 89Bio Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does 89Bio Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for 89Bio Inc
These potential risks are based on the size, segment and geographies of the company.
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.